Citations (104)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
Arne van den Bos, Eric Blaauw & Bert Bieleman. (2023) University students and the normalisation of illicit recreational drug use. Journal of Youth Studies 26:7, pages 894-906.
Read now
Read now
Beate Peter & Lisa Williams. (2022) One Foot in the Rave: Aging Ravers’ Transitions to Adulthood and Their Participation in Rave Culture. Leisure Sciences 44:7, pages 808-826.
Read now
Read now
David Rowlands, Donna Youngs & David Canter. (2020) Agency and communion: modeling identity-transformation in recovery from substance misuse. Journal of Substance Use 25:2, pages 163-172.
Read now
Read now
David Rowlands, Donna Youngs & David Canter. (2019) Exploring an agency-communion model of identity transformation in recovery from substance misuse. Journal of Substance Use 24:3, pages 265-272.
Read now
Read now
Jamie Hakim. (2019) The rise of chemsex: queering collective intimacy in neoliberal London. Cultural Studies 33:2, pages 249-275.
Read now
Read now
Ian P. Albery, Antony C. Moss, Nicola Davidson, S. Mba, Ursula Blaszko & Alexander P. Marchant. (2018) Selective attentional bias for novel psychoactive substance (NPS) and expectancy-related stimuli among nonproblematic NPS users and never NPS users. Journal of Substance Use 23:4, pages 422-428.
Read now
Read now
Alex Pollard, Tom Nadarzynski & Carrie Llewellyn. (2018) Syndemics of stigma, minority-stress, maladaptive coping, risk environments and littoral spaces among men who have sex with men using chemsex. Culture, Health & Sexuality 20:4, pages 411-427.
Read now
Read now
Vendula Belackova, Jaroslav Vacek, Barbara Janikova, Viktor Mravcik, Tomas Zabransky, Lucie Ivanovova & Ladislav Csemy. (2017) “Just another drug” for marginalized users: The risks of using synthetic cathinones among NSP clients in the Czech Republic. Journal of Substance Use 22:6, pages 567-573.
Read now
Read now
Kirsten Elin Smith, Amanda M. Bunting, Michele Staton, Robert Walker, Sara Shalash, Erin Winston & Kevin Pangburn. (2017) Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013–2015. Journal of Psychoactive Drugs 49:5, pages 436-445.
Read now
Read now
Lisa Williams, Rob Ralphs & Paul Gray. (2017) The Normalization of Cannabis Use Among Bangladeshi and Pakistani Youth: A New Frontier for the Normalization Thesis?. Substance Use & Misuse 52:4, pages 413-421.
Read now
Read now
Wui Ling Chan, David M. Wood & Paul I. Dargan. (2016) Misuse of prescription and over-the-counter medicines in South London nightclubs. Journal of Substance Use 21:5, pages 495-500.
Read now
Read now
Alison M Dines, David M Wood, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon, Roumen Sedefov & Paul I Dargan. (2015) Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN). Clinical Toxicology 53:9, pages 893-900.
Read now
Read now
Jonathan Taylor. (2015) The Stimulants of Prohibition: Illegality and New Synthetic Drugs. Territory, Politics, Governance 3:4, pages 407-427.
Read now
Read now
Wui Ling Chan, David Michael Wood & Paul Ivor Dargan. (2015) Significant Misuse of Sildenafil in London Nightclubs. Substance Use & Misuse 50:11, pages 1390-1394.
Read now
Read now
Peter Miller, Nicolas Droste, Florentine Martino, Darren Palmer, Jennifer Tindall, Karen Gillham & John Wiggers. (2015) Illicit drug use and experience of harm in the night-time economy. Journal of Substance Use 20:4, pages 274-281.
Read now
Read now
Kate O'Brien, Caroline Chatwin, Charlie Jenkins & Fiona Measham. (2015) New psychoactive substances and British drug policy: A view from the cyber-psychonauts. Drugs: Education, Prevention and Policy 22:3, pages 217-223.
Read now
Read now
. (2014) XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 27–30 May 2014, Brussels, Belgium. Clinical Toxicology 52:4, pages 295-443.
Read now
Read now
J. R. H. Archer, P. I. Dargan, H. M. D. Lee, S. Hudson & D. M. Wood. (2014) Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances. Clinical Toxicology 52:3, pages 160-165.
Read now
Read now
J. R. H Archer, P. I. Dargan, S. Hudson, S. Davies, M. Puchnarewicz, A. T. Kicman, J. Ramsey, F. Measham, M. Wood, A. Johnston & D. M. Wood. (2014) Taking the Pissoir – a novel and reliable way of knowing what drugs are being used in nightclubs. Journal of Substance Use 19:1-2, pages 103-107.
Read now
Read now
. (2013) XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 28–31 May 2013, Copenhagen, Denmark. Clinical Toxicology 51:4, pages 252-378.
Read now
Read now
J. R. H. Archer, P. I. Dargan, D. M. Wood & A. R. Winstock. (2013) Hospital and prehospital emergency service utilisation as an impact of acute recreational drug and ethanol toxicity. Journal of Substance Use 18:2, pages 129-137.
Read now
Read now
David M. Wood & Paul I. Dargan. (2012) Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP). Clinical Toxicology 50:8, pages 727-732.
Read now
Read now
David M. Wood, Fiona Measham & Paul I. Dargan. (2012) ‘Our favourite drug’: prevalence of use and preference for mephedrone in the London night-time economy 1 year after control. Journal of Substance Use 17:2, pages 91-97.
Read now
Read now
Marie Claire Van Hout & Rebekah Brennan. (2012) Curiosity killed M-Cat: A post-legislative study on mephedrone use in Ireland. Drugs: Education, Prevention and Policy 19:2, pages 156-162.
Read now
Read now
Articles from other publishers (80)
Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, Ornella Corazza, Aurora Coppola & Gianluca Esposito. (2023) The novel psychoactive substances epidemic: A scientometric perspective. Addiction Neuroscience 5, pages 100060.
Crossref
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
131
156
.
Kerry Layne, Paul I. Dargan & David M. Wood. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
333
380
.
Fiona Measham. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
157
180
.
Dirk Korf, Annemieke Benschop, Bernd Werse, Gerrit Kamphausen, Katalin Felvinczi, Katarzyna Dąbrowska, Susana Hernriques, Ton Nabben, Łukasz Wieczorek, Michał Bujalski, Zsusza Kalo, Evelyn Hearne & Marie Claire Van Hout. (2019) How and Where to Find NPS Users: a Comparison of Methods in a Cross-National Survey Among Three Groups of Current Users of New Psychoactive Substances in Europe. International Journal of Mental Health and Addiction 19:4, pages 873-890.
Crossref
Crossref
Michael J. Kyron, Peter M. McEvoy, Dylan Gilbey, Ashleigh Lin, Catherine Mazza, Wavne Rikkers, Jennifer Bartlett & David Lawrence. (2021) Sexual orientation and prevalence of mental health difficulties among emergency services employees. Journal of Affective Disorders 287, pages 240-246.
Crossref
Crossref
Owen Bowden-Jones & Dima Abdulrahim. 2020. Club Drugs and Novel Psychoactive Substances. Club Drugs and Novel Psychoactive Substances.
Andrew Gilliver & Clare Marshall. (2020) Having pride in your practice. BDJ Team 7:7, pages 10-13.
Crossref
Crossref
Y.J. Evers, C.J.P.A. Hoebe, N.H.T.M. Dukers-Muijrers, C.J.G. Kampman, S. Kuizenga-Wessel, D. Shilue, N.C.M. Bakker, S.M.A.A. Schamp, H. Van Buel, W.C.J.P.M. Van Der Meijden & G.A.F.S. Van Liere. (2020) Sexual, addiction and mental health care needs among men who have sex with men practicing chemsex – a cross-sectional study in the Netherlands. Preventive Medicine Reports 18, pages 101074.
Crossref
Crossref
Kiran Pienaar, Dean Anthony Murphy, Kane Race & Toby Lea. (2020) Drugs as technologies of the self: Enhancement and transformation in LGBTQ cultures. International Journal of Drug Policy 78, pages 102673.
Crossref
Crossref
Kiran Pienaar, Dean Murphy, Kane Race & Toby Lea. 2020. Cultures of Intoxication. Cultures of Intoxication
139
163
.
Fiona Hutton. 2020. Cultures of Intoxication. Cultures of Intoxication
87
110
.
Bernd Werse, Annemieke Benschop, Gerrit Kamphausen, Marie-Claire van Hout, Susana Henriques, Joana Paula Silva, Katarzyna Dąbrowska, Łukasz Wieczorek, Michał Bujalski, Katalin Felvinczi & Dirk Korf. (2018) Sharing, Group-Buying, Social Supply, Offline and Online Dealers: how Users in a Sample from Six European Countries Procure New Psychoactive Substances (NPS). International Journal of Mental Health and Addiction 17:5, pages 1237-1251.
Crossref
Crossref
Kathryn Higgins, Nina O’Neill, Leeanne O’Hara, Julie-Ann Jordan, Mark McCann, Tara O’Neill, Mike Clarke, Tony O’Neill & Anne Campbell. (2019) Evidence for public health on novel psychoactive substance use: a mixed-methods study. Public Health Research 7:14, pages 1-150.
Crossref
Crossref
Kirsten E. Smith & William W. Stoops. (2019) Synthetic Cathinone Use Among Polysubstance Users: Indirect Indicator of Indiscriminate Drug Taking or Preferred Drug of Abuse?. Journal of Drug Issues 49:2, pages 369-386.
Crossref
Crossref
Tim Turner & Fiona Measham. 2019. Young Adult Drinking Styles. Young Adult Drinking Styles
87
114
.
David Patton. (2018) Navigating drugs at university: normalisation, differentiation and drift?. Safer Communities 17:4, pages 224-237.
Crossref
Crossref
Nick Meader, Noreen Mdege & Jim McCambridge. (2018) The public health evidence-base on novel psychoactive substance use: scoping review with narrative synthesis of selected bodies of evidence. Journal of Public Health 40:3, pages e303-e319.
Crossref
Crossref
Niamh Joyce, Pádraig MacNeela, Kiran Sarma, Graham Ryall & Eamon Keenan. (2017) The Experience and Meaning of Problematic ‘G’ (GHB/GBL) Use in an Irish Context: an Interpretative Phenomenological Analysis. International Journal of Mental Health and Addiction 16:4, pages 1033-1054.
Crossref
Crossref
Marie Claire Van Hout, Annemieke Benschop, Michal Bujalski, Katarzyna Dąbrowska, Zsolt Demetrovics, Katalin Felvinczi, Evelyn Hearne, Susana Henriques, Zsuzsa Kaló, Gerrit Kamphausen, Dirk Korf, Joana Paula Silva, Łukasz Wieczorek & Bernd Werse. (2017) Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries. International Journal of Mental Health and Addiction 16:2, pages 480-495.
Crossref
Crossref
Rosalind Gittins, Amira Guirguis, Fabrizio Schifano & Ian Maidment. (2018) Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK. Brain Sciences 8:4, pages 58.
Crossref
Crossref
Caroline ChatwinCaroline Chatwin. 2018. Towards More Effective Global Drug Policies. Towards More Effective Global Drug Policies
21
51
.
John M. Corkery, Amira Guirguis, Duccio G. Papanti, Laura Orsolini & Fabrizio Schifano. 2018. Synthetic Cathinones. Synthetic Cathinones
153
189
.
Lysa S. Remy, Juliana Scherer, Luciano Guimarães, Hilary L. Surratt, Steven P. Kurtz, Flavio Pechansky & Felix Kessler. (2017) Anxiety and depression symptoms in Brazilian sexual minority ecstasy and LSD users. Trends in Psychiatry and Psychotherapy 39:4, pages 239-246.
Crossref
Crossref
Raven Egheosa Owie, Paul Gosney, Andrew Roney & Aileen O’Brien. (2017) Psychiatrists’ knowledge of novel psychoactive substances. Drugs and Alcohol Today 17:3, pages 178-185.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
P Weatherburn, F Hickson, D Reid, S Torres-Rueda & A Bourne. (2017) Motivations and values associated with combining sex and illicit drugs (‘chemsex’) among gay men in South London: findings from a qualitative study. Sexually Transmitted Infections 93:3, pages 203-206.
Crossref
Crossref
Giovanni Martinotti, Eduardo Cinosi, Rita Santacroce, Duccio Papanti, Anna Pasquini, Valerio Mancini, Mariangela Corbo, Federica Fiori, Fabiola Sarchione, Daniela Marchetti, Maria Cristina Verrocchio, Massimo Di Giannantonio, Marta Torrens, Fabrizio Schifano, Maria Jose Morlan Coarasa & Cristina Merino del Villar. (2017) Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza. Human Psychopharmacology: Clinical and Experimental 32:3, pages e2586.
Crossref
Crossref
Elena Deligianni, John M. Corkery, Fabrizio Schifano & Lisa A. Lione. (2017) An international survey on the awareness, use, preference, and health perception of novel psychoactive substances (NPS). Human Psychopharmacology: Clinical and Experimental 32:3, pages e2581.
Crossref
Crossref
Owen Bowden-Jones, Claire Whitelock, Dima Abdulrahim, Stacey Hemmings, Alexander Margetts & Michael Crawford. (2017) Prevalence of HIV risk-related drug use and sexual activity among men who have sex with men attending a specialist UK club drug clinic. Drugs and Alcohol Today 17:1, pages 50-59.
Crossref
Crossref
Michal Pitoňák. (2017) Mental health in non-heterosexuals: Minority stress theory and related explanation frameworks review. Mental Health & Prevention 5, pages 63-73.
Crossref
Crossref
Caroline Chatwin, Fiona Measham, Kate O’Brien & Harry Sumnall. (2017) New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs. International Journal of Drug Policy 40, pages 1-5.
Crossref
Crossref
Rob Ralphs, Lisa Williams, Rebecca Askew & Anna Norton. (2017) Adding Spice to the Porridge11‘Porridge’ is British slang for a prison sentence. E.g. ‘Doing his porridge’. The term is most commonly thought to be an allusion to the fact that porridge is, or used to be, a common food in prison. The term is also thought to be a pun on the much older slang word for prison, ‘stir’.: The development of a synthetic cannabinoid market in an English prison. International Journal of Drug Policy 40, pages 57-69.
Crossref
Crossref
Z Ottaway, Fionnuala Finnerty, Aliza Amlani, Nicolas Pinto-Sander, Joshua Szanyi & Daniel Richardson. (2016) Men who have sex with men diagnosed with a sexually transmitted infection are significantly more likely to engage in sexualised drug use. International Journal of STD & AIDS 28:1, pages 91-93.
Crossref
Crossref
Kane Race, Toby Lea, Dean Murphy & Kiran Pienaar. (2017) The future of drugs: recreational drug use and sexual health among gay and other men who have sex with men. Sexual Health 14:1, pages 42.
Crossref
Crossref
Chris Wilkins, Marta Rychert, Bogumiła Byrska, Marie Claire Van Hout, Ornella Corazza & Andres Roman-Urrestarazu. 2017. Novel Psychoactive Substances. Novel Psychoactive Substances
57
74
.
Dianne L. Kerr & Willie H. Oglesby. 2017. Research Methods in the Study of Substance Abuse. Research Methods in the Study of Substance Abuse
341
355
.
Rachelle Abouchedid & David M. Wood. 2017. Critical Care Toxicology. Critical Care Toxicology
1485
1524
.
David M. Wood. 2017. Critical Care Toxicology. Critical Care Toxicology
1555
1586
.
Alysha-Karima Ahmed, Peter Weatherburn, David Reid, Ford Hickson, Sergio Torres-Rueda, Paul Steinberg & Adam Bourne. (2016) Social norms related to combining drugs and sex (“chemsex”) among gay men in South London. International Journal of Drug Policy 38, pages 29-35.
Crossref
Crossref
Trond Nordfjærn, Anne Line Bretteville-Jensen, Marit Edland-Gryt & Johanna Gripenberg. (2016) Risky substance use among young adults in the nightlife arena: An underused setting for risk-reducing interventions?. Scandinavian Journal of Public Health 44:7, pages 638-645.
Crossref
Crossref
A. Kolliakou, M. Ball, L. Derczynski, D. Chandran, G. Gkotsis, P. Deluca, R. Jackson, H. Shetty & R. Stewart. (2020) Novel psychoactive substances: An investigation of temporal trends in social media and electronic health records. European Psychiatry 38, pages 15-21.
Crossref
Crossref
Tait Mandler. (2016) Producing Pleasure, Minimizing Harm. Contemporary Drug Problems 43:3, pages 258-276.
Crossref
Crossref
Trond Nordfjærn, Marit Edland-Gryt, Anne Line Bretteville-Jensen, Kristin Buvik & Johanna Gripenberg. (2016) Recreational drug use in the Oslo nightlife setting: study protocol for a cross-sectional time series using biological markers, self-reported and qualitative data. BMJ Open 6:4, pages e009306.
Crossref
Crossref
Helen Dolengevich-Segal, Beatriz Rodr?guez-Salgado, Jorge G?mez-Arnau & Daniel S?nchez-Mateos. (2016)
Severe Psychosis, Drug Dependence, and Hepatitis C Related to
Slamming
Mephedrone
. Case Reports in Psychiatry 2016, pages 1-5.
Crossref
Crossref
Rachelle Abouchedid & David M. Wood. 2016. Critical Care Toxicology. Critical Care Toxicology
1
40
.
David M. Wood. 2016. Critical Care Toxicology. Critical Care Toxicology
1
32
.
J.R.H. Archer, S. Hudson, O. Jackson, T. Yamamoto, C. Lovett, H.M. Lee, S. Rao, L. Hunter, P.I. Dargan & D.M. Wood. (2015) Analysis of anonymized pooled urine in nine UK cities: variation in classical recreational drug, novel psychoactive substance and anabolic steroid use. QJM 108:12, pages 929-933.
Crossref
Crossref
Adam Bourne, David Reid, Ford Hickson, Sergio Torres-Rueda, Paul Steinberg & Peter Weatherburn. (2015) “Chemsex” and harm reduction need among gay men in South London. International Journal of Drug Policy 26:12, pages 1171-1176.
Crossref
Crossref
Bobby P. Smyth, Philip James, Walter Cullen & Catherine Darker. (2015) ?So prohibition can work?? Changes in use of novel psychoactive substances among adolescents attending a drug and alcohol treatment service following a legislative ban. International Journal of Drug Policy 26:9, pages 887-889.
Crossref
Crossref
John M. Corkery, Barbara Loi, Hugh Claridge, Christine Goodair, Ornella Corazza, Simon Elliott & Fabrizio Schifano. (2015) Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use. Neuroscience & Biobehavioral Reviews 53, pages 52-78.
Crossref
Crossref
Shwetha Rao, David Wood & Paul Dargan. 2015. Ketamine. Ketamine
103
144
.
Caitlyn Lovett, T. Yamamoto, Laura Hunter, John White, Paul I. Dargan & David M. Wood. (2015) Problematic recreational drug use: is there a role for outpatient sexual health clinics in identifying those not already engaged with treatment services?. Sexual Health 12:6, pages 501.
Crossref
Crossref
Nina O'Neill. (2014) Mephedrone and Multiplicity: User Accounts of Effects and Harms. Contemporary Drug Problems 41:3, pages 417-443.
Crossref
Crossref
Christopher D Smith & Stefanie Robert. (2014) ‘Designer drugs’: update on the management of novel psychoactive substance misuse in the acute care setting. Clinical Medicine 14:4, pages 409-415.
Crossref
Crossref
Alex Stevens & Fiona Measham. (2014) The ‘drug policy ratchet’: why do sanctions for new psychoactive drugs typically only go up?. Addiction 109:8, pages 1226-1232.
Crossref
Crossref
L J Hunter, P I Dargan, A Benzie, J A White & D M Wood. (2014) Recreational drug use in men who have sex with men (MSM) attending UK sexual health services is significantly higher than in non-MSM. Postgraduate Medical Journal 90:1061, pages 133-138.
Crossref
Crossref
Christophe Soussan & Anette Kjellgren. (2014) Harm reduction and knowledge exchange—a qualitative analysis of drug-related Internet discussion forums. Harm Reduction Journal 11:1, pages 25.
Crossref
Crossref
Maria João Valente, Paula Guedes de Pinho, Maria de Lourdes Bastos, Félix Carvalho & Márcia Carvalho. (2013) Khat and synthetic cathinones: a review. Archives of Toxicology 88:1, pages 15-45.
Crossref
Crossref
Neil McKeganeyNeil McKeganey. 2014. A–Z of Substance Misuse and Drug Addiction. A–Z of Substance Misuse and Drug Addiction
84
91
.
T. Yamamoto, A. Kawsar, J. Ramsey, P. I. Dargan & D. M. Wood. (2013) Monitoring trends in recreational drug use from the analysis of the contents of amnesty bins in gay dance clubs. QJM 106:12, pages 1111-1117.
Crossref
Crossref
Paul Griffiths, Michael Evans‐Brown & Roumen Sedefov. (2013) Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age. Addiction 108:10, pages 1700-1703.
Crossref
Crossref
John M. Stogner & Bryan Lee Miller. (2013) Investigating the ‘bath salt’ panic: The rarity of synthetic cathinone use among students in the United States. Drug and Alcohol Review, pages n/a-n/a.
Crossref
Crossref
Jan van Amsterdam, David NuttWim van den Brink. (2013) Generic legislation of new psychoactive drugs. Journal of Psychopharmacology 27:3, pages 317-324.
Crossref
Crossref
David McQuade, Simon Hudson, Paul I. Dargan & David M. Wood. (2012) First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. European Journal of Clinical Pharmacology 69:3, pages 373-376.
Crossref
Crossref
J. R. H. Archer, P. I. Dargan, S. Hudson & D. M. Wood. (2012) Analysis of anonymous pooled urine from portable urinals in central London confirms the significant use of novel psychoactive substances. QJM 106:2, pages 147-152.
Crossref
Crossref
Karenza Moore, Paul I. Dargan, David M. Wood & Fiona Measham. (2013) Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation The relationship between Mephedrone, Ecstasy and Cocaine. European Addiction Research 19:5, pages 276-282.
Crossref
Crossref
Toby Lea, Garrett Prestage, Limin Mao, Iryna Zablotska, John de Wit & Martin Holt. (2012)
Trends in drug use among gay and bisexual men in
S
ydney,
M
elbourne and
Q
ueensland,
A
ustralia
. Drug and Alcohol Review 32:1, pages 39-46.
Crossref
Crossref
Simon D. Brandt, Robin A. Braithwaite, Michael Evans-Brown & Andrew T. Kicman. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
261
283
.
David M. Wood & Paul I. Dargan. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
211
231
.
Fiona Measham. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
105
127
.
Harry Sumnall, James McVeigh & Michael J. Evans-Brown. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
79
103
.
Rebekah Brennan & Marie Claire Van Hout. (2012) Miaow miaow: a review of the new psychoactive drug mephedrone. Drugs and Alcohol Today 12:4, pages 241-253.
Crossref
Crossref
D. M. Wood, L. Hunter, F. Measham & P. I. Dargan. (2012) Limited use of novel psychoactive substances in South London nightclubs. QJM 105:10, pages 959-964.
Crossref
Crossref
Karenza Moore & Fiona Measham. (2012) The Silent “G”: A Case Study in the Production of “Drugs” and “Drug Problems”. Contemporary Drug Problems 39:3, pages 565-590.
Crossref
Crossref
D. M. Wood & P. I. Dargan. (2012) Understanding How Data Triangulation Identifies Acute Toxicity of Novel Psychoactive Drugs. Journal of Medical Toxicology 8:3, pages 300-303.
Crossref
Crossref
David M. Wood & Paul I. Dargan. (2012) Novel Psychoactive Substances. Therapeutic Drug Monitoring 34:4, pages 363-367.
Crossref
Crossref
Marie Claire Van Hout & Tim Bingham. (2012) “A Costly Turn On”: Patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors. International Journal of Drug Policy 23:3, pages 188-197.
Crossref
Crossref
Alasdair J.M. Forsyth. (2012) Virtually a drug scare: Mephedrone and the impact of the Internet on drug news transmission. International Journal of Drug Policy 23:3, pages 198-209.
Crossref
Crossref
Fiona Measham, Karenza Moore & Jeanette Østergaard. (2011) Mephedrone, “Bubble” and unidentified white powders: the contested identities of synthetic “legal highs”. Drugs and Alcohol Today 11:3, pages 137-146.
Crossref
Crossref